revumenib
syndax pharma
['thanks', 'leukemia', 'revumenib']
the menin inhibitor revumenib is a promising new drug to treat aggressive #leukemia thanks to work by eytan stein, , , , scott armstrong, + team. will present data on acquired resistance today at #aacr23. 
The official account of @MSKCancerCenter’s Department of Medicine. Chair/Dept. Head: @debschrag